USANA Health Sciences, Inc. (NYSE:USNA) insider Daniel A. Macuga sold 5,751 shares of the firm’s stock in a transaction on Monday, August 28th. The shares were sold at an average price of $60.00, for a total transaction of $345,060.00. Following the transaction, the insider now directly owns 2,077 shares of the company’s stock, valued at approximately $124,620. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

USANA Health Sciences, Inc. (NYSE:USNA) opened at 59.20 on Friday. The company’s 50-day moving average is $59.06 and its 200-day moving average is $60.22. The company has a market cap of $1.45 billion, a P/E ratio of 15.38 and a beta of 1.10. USANA Health Sciences, Inc. has a 52 week low of $52.55 and a 52 week high of $75.00.

USANA Health Sciences (NYSE:USNA) last announced its quarterly earnings data on Tuesday, July 25th. The company reported $0.98 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.06 by $0.08. The business had revenue of $257.10 million during the quarter, compared to analysts’ expectations of $273.61 million. USANA Health Sciences had a net margin of 9.47% and a return on equity of 28.93%. USANA Health Sciences’s revenue for the quarter was down .5% on a year-over-year basis. During the same period last year, the company posted $2.07 EPS. On average, analysts anticipate that USANA Health Sciences, Inc. will post $3.79 EPS for the current fiscal year.

USANA Health Sciences announced that its Board of Directors has authorized a stock buyback plan on Tuesday, July 25th that permits the company to buyback $64.60 million in shares. This buyback authorization permits the company to buy up to 46% of its shares through open market purchases. Shares buyback plans are generally a sign that the company’s leadership believes its stock is undervalued.

WARNING: “Insider Selling: USANA Health Sciences, Inc. (USNA) Insider Sells $345,060.00 in Stock” was posted by Watch List News and is owned by of Watch List News. If you are viewing this story on another publication, it was stolen and reposted in violation of US & international trademark and copyright laws. The correct version of this story can be read at https://www.watchlistnews.com/insider-selling-usana-health-sciences-inc-usna-insider-sells-345060-00-in-stock/1535578.html.

A number of brokerages recently weighed in on USNA. BidaskClub downgraded shares of USANA Health Sciences from a “sell” rating to a “strong sell” rating in a research note on Monday, July 31st. Pivotal Research lowered their target price on shares of USANA Health Sciences from $75.00 to $70.00 and set a “buy” rating for the company in a research note on Wednesday, July 26th.

A number of large investors have recently made changes to their positions in the stock. American International Group Inc. boosted its stake in shares of USANA Health Sciences by 7.1% in the first quarter. American International Group Inc. now owns 6,392 shares of the company’s stock valued at $368,000 after buying an additional 422 shares during the last quarter. Prudential Financial Inc. boosted its stake in shares of USANA Health Sciences by 22.4% in the first quarter. Prudential Financial Inc. now owns 69,763 shares of the company’s stock valued at $4,019,000 after buying an additional 12,757 shares during the last quarter. Dynamic Technology Lab Private Ltd purchased a new stake in shares of USANA Health Sciences during the first quarter valued at $515,000. JPMorgan Chase & Co. boosted its stake in shares of USANA Health Sciences by 1.2% in the first quarter. JPMorgan Chase & Co. now owns 16,044 shares of the company’s stock valued at $924,000 after buying an additional 196 shares during the last quarter. Finally, MARSHALL WACE ASIA Ltd purchased a new stake in shares of USANA Health Sciences during the first quarter valued at $1,436,000. 44.73% of the stock is owned by institutional investors and hedge funds.

About USANA Health Sciences

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.

Insider Buying and Selling by Quarter for USANA Health Sciences (NYSE:USNA)

Receive News & Ratings for USANA Health Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.